Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-07-03T05:21:15.683Z Has data issue: false hasContentIssue false

P03-239 - Compliance Of Opiate Addicted Patients Treated With Buprenorphine

Published online by Cambridge University Press:  17 April 2020

M. Guillou Landreat
Affiliation:
Addictology, CH Pays De Morlaix, Morlaix, France
V. Sebille Rivain
Affiliation:
Medicine Faculty, Nantes, France
C. Victorri Vigneau
Affiliation:
Medicine Faculty, Nantes, France
Y. Foucher
Affiliation:
Université de Nantes, Nantes, France
M. Grall Bronnec
Affiliation:
Medicine Faculty, Nantes, France
J.L. Venisse
Affiliation:
Medicine Faculty, Nantes, France
P. Jolliet
Affiliation:
Medicine Faculty, Nantes, France

Abstract

Background

The French experience regarding treatment of opiates addiction with buprenorphine is exceptional. However drug compliance is one of the most important prognostic factors for this treatment efficacy, but there are very few data on the subject in literature.

Purpose

The main purpose of our study was to analyze the compliance of opiate-addicted patients treated with buprenorphine.

Method

We have carried out a forecast study on drug compliance of buprenorphine treatments on a 10-year period using a software specifically designed to that end. We have performed a statistical analysis of the conditions and transitions of opiate-addicted patients treated with buprenorphine along appointments.

Results

We have shown that there was a good compliance to buprenorphine treatments in our population. Moreover, we have identified factors linked to a development towards bad compliance, such as criminal records or addictive behaviors among the patient's social circle.

Conclusion

Our results allow a better understanding of the factors of compliance in treated opiate-addicted patients and allow to debate ways to improve this compliance.

Type
Substance related disorders
Copyright
Copyright © European Psychiatric Association 2010

This study was supported by a grant from the French MILDT.

Submit a response

Comments

No Comments have been published for this article.